Is flow cytometry or quantitative polymerase chain reaction (PCR) better for HLA‑B27 typing?

HLA-B27 Testing: Flow Cytometry vs PCR

For HLA-B27 typing, PCR-based molecular methods are superior to flow cytometry, with allele-specific real-time PCR demonstrating 100% sensitivity and 100% specificity compared to flow cytometry's 98% sensitivity and 38.5% specificity. 1, 2

Comparative Performance Data

Flow Cytometry Performance

• Sensitivity: 98-99.6% 1, 3
• Specificity: 38.5-97.6% (highly variable depending on antibody clone used) 1, 3
• Positive Predictive Value: 85.7% 1
• False positive rate: Significant issue, particularly with cross-reactivity to HLA-B*07:02 alleles 4
• False negative rate: Occurs in approximately 2% of cases 3, 5

PCR-Based Methods Performance

• Allele-specific RT-PCR: 100% sensitivity and 100% specificity when using cascade approach with exon 2 and 3 analysis 2
• PCR with melting curve analysis: 99.6% sensitivity and 100% specificity 3
• Next-generation sequencing (NGS): Superior accuracy with ability to distinguish pathogenic from non-pathogenic B27 variants 4

Critical Clinical Advantages of PCR Over Flow Cytometry

Specificity Issues with Flow Cytometry

Flow cytometry demonstrates problematic cross-reactivity with HLA-B07:02, leading to false positive results that cannot be distinguished without molecular confirmation 4. In one study, 15.5% of flow cytometry "indeterminate" results were actually HLA-B07:02 positive (not HLA-B27) 4.

Allele-Level Resolution

Only molecular methods can distinguish between pathogenic and non-pathogenic HLA-B27 subtypes, which is clinically relevant since HLA-B*27:06 is NOT associated with ankylosing spondylitis risk, while other B27 subtypes are 4, 6. Flow cytometry cannot make this distinction 4.

Antibody-Dependent Variability

Flow cytometry performance depends heavily on which monoclonal antibody clone is used (HLA-ABC-m3, GS145.2, or FD705), with no single antibody providing 100% accuracy 5. Even using two different antibodies simultaneously does not eliminate false results 5.

Recommended Testing Algorithm

Based on cost-effectiveness and diagnostic accuracy, implement this cascade approach:

1. Initial screening: Flow cytometry (if cost is primary concern in resource-limited settings) 1
2. Reflex to PCR: For ALL negative flow cytometry results when clinical suspicion remains high 1, 5
3. Reflex to PCR: For ALL indeterminate flow cytometry results 4
4. Consider NGS: When allele-level typing is needed to distinguish pathogenic variants (e.g., ruling out B*27:06) 4, 6

However, if resources permit, proceed directly to PCR-based testing to avoid the need for reflex testing and eliminate false positives/negatives from flow cytometry 2, 3.

Cost-Benefit Considerations

While flow cytometry is less expensive and faster than PCR 1, 3, the high false positive rate (specificity 38.5%) means substantial additional costs from unnecessary follow-up testing and potential misdiagnosis 1. The cascade algorithm (flow cytometry first, then PCR for negatives with high clinical suspicion) balances cost and accuracy in low-resource settings 1, 5.

Common Pitfalls to Avoid

• Do not rely solely on flow cytometry positive results without molecular confirmation, especially in populations with high HLA-B*07:02 prevalence 4
• Do not accept flow cytometry negative results as definitive when clinical features strongly suggest axial spondyloarthritis—reflex to PCR 1, 5
• Do not assume all HLA-B27 subtypes carry equal disease risk—only molecular methods can identify the non-pathogenic B*27:06 variant 4, 6
• Avoid using flow cytometry as the sole method in heterogeneous populations where cross-reactive alleles are common 2